Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-03

FDA Approved: ATENOLOL AND CHLORTHALIDONE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for the atenolol and chlorthalidone combination from Actavis Pharma, indicating regulatory approval for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATENOLOL AND CHLORTHALIDONE (Atenolol and chlorthalidone)

Snippet

SUPPL AP for ATENOLOL AND CHLORTHALIDONE (ATENOLOL AND CHLORTHALIDONE)